Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

MIT has developed a DNA sensor that can detect HPV and HIV infections through voltage changes. The sensor is durable and ...

The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...

Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to ...

Dorr et al. [3] evaluated maraviroc's antiretroviral activity against primary isolates of HIV-1, Group M (clades B and non-B) and Group O. The geometric mean concentration required to inhibit 90% ...

A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.

The researchers at the National Cancer Institute leveraged data from the HIV/AIDS Cancer Match Study, which covers 13 US states and the District of Columbia. For this analysis, they examined ...

WASHINGTON — A newly approved HIV prevention drug that requires just two doses a year is generating excitement among health professionals in Colorado and across the U.S., who hope it will help ...

The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir The molecule that ‘breaks all the rules’ is a game-changer Nardus Engelbrecht By William Pao June 23, 2025 ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear ...

Upward of 2,500 riders meet in Northern California each year to raise money and support for HIV and AIDS prevention and care. Since 1994, the ride has raised over $300 million for the San ...